Signature Drug Toxicity News

An early-stage study published online today in the International Journal of Cancer says that a drug already approved for the treatment of lymphoma may also slow the growth of the most... Read more

The US FDA has released drug dosage guidance as part of its Safe Use Initiative, intended to help both patients and caregivers.

The agency’s report “Dosage Delivery Devices for OTC L... Read more

Abbott’s drug eluting stents, XIENCE PRIME™ Everolimus Eluting Coronary Stent System and the XIENCE V® Everolimus Eluting Coronary Stent System have both received additional new CE Markings ... Read more

A novel computer program has identified thousands of new targets for existing drugs by comparing the molecular structures of drug compounds and chemicals that occur naturally in the body. Read more

A new drug that is claimed to be effective in killing leukemia cells has been developed by researchers at Trinity College Dublin in partnership with the University of Sienna in Italy, St Jam... Read more

A nano-scale drug delivery method that has been found to effectively eliminate cancer tumours after a single treatment has been developed by a research team led by Indian-origin sci... Read more

Dosage should be increased to make gout drug effective, say New Zealand researchers.

They have established that thousands of gout sufferers may have been taking too lower dose of the... Read more

Researchers say that a cocktail of three drugs, already on the market, offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu.

Mark Prichard, a ... Read more

Reports say scientists are working on the formulation of a new drug that may slow down diseases like Parkinson's, Alzheimer's and Huntington's.

Professor Hagit Eldar-Finkelman of... Read more

A Henry Ford study has revealed that a drug approved for neuropathic pain, effectively reduced abdominal pain and improved sleep in women with adhesions.

Adhesion pain, a common... Read more